Indication
Chronic Lung Transplant Rejection
4 clinical trials
4 products
Clinical trial
A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung TransplantStatus: Active (not recruiting), Estimated PCD: 2024-04-05
Product
Liposomal Cyclosporine AProduct
Standard of CareClinical trial
A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung TransplantStatus: Active (not recruiting), Estimated PCD: 2024-04-05
Clinical trial
A Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung TransplantationStatus: Completed, Estimated PCD: 2015-08-01
Clinical trial
A Randomized, Open-label,Controlled Phase II b Study to Demonstrate Efficacy and Safety of Sirolimus Chronic Rejection After Lung TransplantStatus: Withdrawn, Estimated PCD: 2024-06-30
Product
Assigned Interventions